US 11505585
FcRn antagonists and methods of use
granted A61KA61K38/00A61K38/1709
Quick answer
US patent 11505585 (FcRn antagonists and methods of use) held by The Board of Regents of the University of Texas System expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61K38/1709, A61K45/06, A61P